GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
39.01
+1.37 (3.64%)
At close: Apr 3, 2025, 4:00 PM
38.50
-0.51 (-1.31%)
After-hours: Apr 3, 2025, 8:00 PM EDT

GSK Statistics

Total Valuation

GSK has a market cap or net worth of $78.18 billion. The enterprise value is $94.02 billion.

Market Cap 78.18B
Enterprise Value 94.02B

Important Dates

The next confirmed earnings date is Wednesday, April 30, 2025, before market open.

Earnings Date Apr 30, 2025
Ex-Dividend Date Feb 21, 2025

Share Statistics

GSK has 4.08 billion shares outstanding. The number of shares has increased by 0.75% in one year.

Current Share Class n/a
Shares Outstanding 4.08B
Shares Change (YoY) +0.75%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 3.93B

Valuation Ratios

The trailing PE ratio is 24.25 and the forward PE ratio is 8.62.

PE Ratio 24.25
Forward PE 8.62
PS Ratio 1.99
Forward PS 2.38
PB Ratio 4.77
P/TBV Ratio n/a
P/FCF Ratio 11.58
P/OCF Ratio 9.53
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.03, with an EV/FCF ratio of 13.93.

EV / Earnings 29.17
EV / Sales 2.39
EV / EBITDA 9.03
EV / EBIT 12.14
EV / FCF 13.93

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.30.

Current Ratio 0.78
Quick Ratio 0.50
Debt / Equity 1.30
Debt / EBITDA 1.99
Debt / FCF 3.15
Interest Coverage 10.06

Financial Efficiency

Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 12.70%.

Return on Equity (ROE) 22.80%
Return on Assets (ROA) 6.52%
Return on Invested Capital (ROIC) 12.70%
Return on Capital Employed (ROCE) 16.37%
Revenue Per Employee $572,359
Profits Per Employee $46,973
Employee Count 68,629
Asset Turnover 0.53
Inventory Turnover 1.58

Taxes

In the past 12 months, GSK has paid $658.51 million in taxes.

Income Tax 658.51M
Effective Tax Rate 15.13%

Stock Price Statistics

The stock price has decreased by -6.65% in the last 52 weeks. The beta is 0.29, so GSK's price volatility has been lower than the market average.

Beta (5Y) 0.29
52-Week Price Change -6.65%
50-Day Moving Average 37.54
200-Day Moving Average 37.97
Relative Strength Index (RSI) 54.94
Average Volume (20 Days) 5,080,808

Short Selling Information

Short Interest 17.47M
Short Previous Month 14.05M
Short % of Shares Out 0.86%
Short % of Float n/a
Short Ratio (days to cover) 3.07

Income Statement

In the last 12 months, GSK had revenue of $39.28 billion and earned $3.22 billion in profits. Earnings per share was $0.78.

Revenue 39.28B
Gross Profit 28.21B
Operating Income 7.74B
Pretax Income 6.06B
Net Income 3.22B
EBITDA 10.41B
EBIT 7.74B
Earnings Per Share (EPS) $0.78
Full Income Statement

Balance Sheet

The company has $5.42 billion in cash and $21.27 billion in debt, giving a net cash position of -$15.85 billion or -$3.88 per share.

Cash & Cash Equivalents 5.42B
Total Debt 21.27B
Net Cash -15.85B
Net Cash Per Share -$3.88
Equity (Book Value) 16.38B
Book Value Per Share 4.19
Working Capital -5.88B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $8.21 billion and capital expenditures -$1.75 billion, giving a free cash flow of $6.75 billion.

Operating Cash Flow 8.21B
Capital Expenditures -1.75B
Free Cash Flow 6.75B
FCF Per Share $1.65
Full Cash Flow Statement

Margins

Gross margin is 71.81%, with operating and profit margins of 19.71% and 8.21%.

Gross Margin 71.81%
Operating Margin 19.71%
Pretax Margin 11.08%
Profit Margin 8.21%
EBITDA Margin 26.49%
EBIT Margin 19.71%
FCF Margin 17.18%

Dividends & Yields

This stock pays an annual dividend of $1.55, which amounts to a dividend yield of 3.98%.

Dividend Per Share $1.55
Dividend Yield 3.98%
Dividend Growth (YoY) 6.67%
Years of Dividend Growth 1
Payout Ratio 199.25%
Buyback Yield -0.75%
Shareholder Yield 3.22%
Earnings Yield 4.12%
FCF Yield 8.63%
Dividend Details

Analyst Forecast

The average price target for GSK is $47.00, which is 20.48% higher than the current price. The consensus rating is "Hold".

Price Target $47.00
Price Target Difference 20.48%
Analyst Consensus Hold
Analyst Count 4
Revenue Growth Forecast (5Y) 3.98%
EPS Growth Forecast (5Y) 28.71%
Stock Forecasts

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8:1.

Last Split Date Jul 19, 2022
Split Type Reverse
Split Ratio 0.8:1

Scores

GSK has an Altman Z-Score of 1.81 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.81
Piotroski F-Score 6